Compounds > pergolide

Page last updated: 2024-08-23

pergolide and quinagolide

pergolide has been researched along with quinagolide in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (14.29)	18.7374
1990's	3 (42.86)	18.2507
2000's	2 (28.57)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Nordmann, R; Petcher, TJ	1
Philosophe, R; Seibel, MM	1
Blackard, WG	1
Conner, P; Fried, G	1
Colao, A; di Sarno, A; di Somma, C; Lombardi, G; Pivonello, R	1
Bankowski, BJ; Zacur, HA	1
Auriemma, RS; Colao, A; Negri, M; Patalano, R; Pirchio, R; Pivonello, C; Pivonello, R	1

Reviews

5 review(s) available for pergolide and quinagolide

Article	Year
Novel approaches to the management of hyperprolactinemia. Current opinion in obstetrics & gynecology, 1991, Volume: 3, Issue:3 Topics: Aminoquinolines; Bromocriptine; Dopamine Agents; Female; Humans; Hyperprolactinemia; Pergolide	1991
Hyperprolactinemia; etiology, diagnosis and treatment alternatives. Acta obstetricia et gynecologica Scandinavica, 1998, Volume: 77, Issue:3 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Pergolide; Prolactin; Receptors, Prolactin	1998
Dopamine receptor agonists for treating prolactinomas. Expert opinion on investigational drugs, 2002, Volume: 11, Issue:6 Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Ergot Alkaloids; Female; Humans; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma	2002
Dopamine agonist therapy for hyperprolactinemia. Clinical obstetrics and gynecology, 2003, Volume: 46, Issue:2 Topics: Aminoquinolines; Benzothiazoles; Bromocriptine; Cabergoline; Clinical Trials as Topic; Dopamine Agonists; Ergolines; Ergoloid Mesylates; Female; Humans; Hyperprolactinemia; Indoles; Pergolide; Pramipexole; Thiazoles	2003
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms. Frontiers in endocrinology, 2021, Volume: 12 Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Aminoquinolines; beta-Arrestins; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Filamins; Growth Hormone-Secreting Pituitary Adenoma; Humans; Lisuride; MicroRNAs; Pergolide; Pituitary Neoplasms; Prolactinoma; Receptors, Dopamine D2	2021

Other Studies

2 other study(ies) available for pergolide and quinagolide

Article	Year
Octahydrobenzo[g]quinolines: potent dopamine agonists which show the relationship between ergolines and apomorphine. Journal of medicinal chemistry, 1985, Volume: 28, Issue:3 Topics: Animals; Apomorphine; Ergolines; Female; Male; Pregnancy; Quinolines; Rats; Receptors, Dopamine; Structure-Activity Relationship	1985
Edema--an infrequently recognized complication of bromocriptine and other ergot dopaminergic drugs. The American journal of medicine, 1993, Volume: 94, Issue:4 Topics: Aminoquinolines; Bromocriptine; Dopamine Agents; Edema; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactinoma	1993